Mackenzie Financial
LEGN icon

Mackenzie Financial’s Legend Biotech LEGN Stock Holding History

Mackenzie Financial’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-25,487
Closed -$548K – 1602
2025
Q4 		$548K Buy
25,487
+2,026
+9% +$58K ﹤0.01% 1203
2025
Q3 		$765K Buy
23,461
+8,431
+56% +$311K ﹤0.01% 1144
2025
Q2 		$533K Buy
+15,030
New +$487K ﹤0.01% 1209
2024
Q2 		– Sell
-162,742
Closed -$9.13M – 1582
2024
Q1 		$9.13M Buy
162,742
+9,975
+7% +$602K 0.01% 460
2023
Q4 		$9.19M Buy
152,767
+23,802
+18% +$1.51M 0.01% 444
2023
Q3 		$8.35M Buy
128,965
+119,658
+1,286% +$8.31M 0.01% 450
2023
Q2 		$641K Buy
+9,307
New +$608K ﹤0.01% 951
2022
Q4 		– Sell
-172,049
Closed -$7.02M – 1517
2022
Q3 		$7.02M Buy
172,049
+43,561
+34% +$2.04M 0.01% 464
2022
Q2 		$7.07M Buy
+128,488
New +$5.43M 0.01% 489
2022
Q1 		– Sell
-23,508
Closed -$1.1M – 1463
2021
Q4 		$1.1M Buy
+23,508
New +$1.19M ﹤0.01% 892

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mackenzie Financial's LEGN Position: Q1 2026 in Review

Mackenzie Financial sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 25,487 shares — an estimated $548K sold.

Mackenzie Financial first reported a position in LEGN in Q4 2021 and held it in 10 quarters. The position peaked at $9.19M in Q4 2023. 191 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Mackenzie Financial reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
  • Mackenzie Financial sold 25,487 Legend Biotech shares in Q1 2026, an estimated $548K.
  • Mackenzie Financial first reported a position in Legend Biotech in Q4 2021 and held it in 10 quarters.
  • Mackenzie Financial's Legend Biotech position peaked at $9.19M in Q4 2023.
  • 191 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.